Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells.

Name: Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells.
Author: Lu, Jun

Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells. — المؤلف: Lu, Jun — BMC medical genomics 20200513

المؤلف: Lu, Jun
النشر: BMC medical genomics 20200513
الوصف: 38 p.
الموضوعات: Antineoplastic Agents؛ Apoptosis؛ Carcinoma, Non-Small-Cell Lung؛ Cell Line, Tumor؛ Cell Movement؛ Chemokine CXCL2؛ Drug Resistance, Neoplasm؛ Gene Expression Profiling